Eurofins Scientific SE Share Price Deutsche Boerse AG

Equities

ESF

FR0000038259

Healthcare Facilities & Services

End-of-day quote Deutsche Boerse AG 23:00:00 04/02/2024 GMT 5-day change 1st Jan Change
53.62 EUR -1.07% Intraday chart for Eurofins Scientific SE -4.59% -9.73%

Financials

Sales 2024 * 7.06B 7.71B 594B Sales 2025 * 7.61B 8.32B 641B Capitalization 9.31B 10.18B 784B
Net income 2024 * 415M 454M 34.94B Net income 2025 * 525M 574M 44.2B EV / Sales 2024 * 1.76 x
Net Debt 2024 * 3.07B 3.36B 259B Net Debt 2025 * 3.04B 3.32B 256B EV / Sales 2025 * 1.62 x
P/E ratio 2024 *
22.3 x
P/E ratio 2025 *
17.8 x
Employees -
Yield 2024 *
1.24%
Yield 2025 *
1.65%
Free-Float 66.78%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 61 31/12/86
Director of Finance/CFO - 31/12/14
Chief Operating Officer - 30/09/19
Members of the board TitleAgeSince
Chief Executive Officer 61 31/12/86
Director/Board Member 58 31/12/91
Director/Board Member 58 31/12/90
More insiders
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
48.3 EUR
Average target price
59.69 EUR
Spread / Average Target
+23.58%
Consensus

Quarterly revenue - Rate of surprise